Novel synthetic plasmid and Doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice

25Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

Abstract

Nucleic acid-based vaccines (NAVs) are a promising alternative to conventional influenza vaccines with the potential to increase influenza vaccine availability due to their simplicity in design and rapid speed of production. NAVs can also target multiple influenza antigens and control flu variants. Traditionally NAVs have been DNA plasmids however, we are continuing to explore new methods that may enhance vaccine efficacy. Recently new focus has been on RNA cassettes as NAVs. RNA vaccines combine conceptual advantages in that they focus on delivery of only the coding cassette. However, RNA vaccines have a short half-life and cause interferon-induced fevers. Here we describe a new NAV approach where we study delivery of a linear DNA cassette [Doggybone™ linear closed DNA [(dbDNA™)] produced by an enzymatic process that yields an antigen expression cassette comprising a promoter, DNA antigen, poly A tail, and telomeric ends. This focused approach has many of the advantages of plasmid DNA as well as a minimal cassette size similar to RNA strategies. For this study, we characterized the specific CD4+ and CD8+ T cell responses and determined the hemagglutination inhibition (HI) titers induced by dbDNA™ and compared the responses with those of an optimized plasmid DNA (pDNA) vaccine encoding the same H1N1 influenza A/PR/8/34 HA gene. Immunizations with the constructs resulted in similar humoral and cellular immune responses. Both constructs induced high-titer HI antibodies and fully protected animals from lethal viral challenge. The data obtained from this study provides important validation for further development of novel vector approaches.

References Powered by Scopus

DNA vaccines: Ready for prime time?

903Citations
N/AReaders
Get full text

The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)

852Citations
N/AReaders
Get full text

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

833Citations
N/AReaders
Get full text

Cited by Powered by Scopus

DNA synthesis technologies to close the gene writing gap

114Citations
N/AReaders
Get full text

A brief review on DNA vaccines in the era of COVID-19

83Citations
N/AReaders
Get full text

AAV capsid design: A Goldilocks challenge

37Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Scott, V. L., Patel, A., Villarreal, D. O., Hensley, S. E., Ragwan, E., Yan, J., … Weiner, D. B. (2015). Novel synthetic plasmid and DoggyboneTM DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice. Human Vaccines and Immunotherapeutics, 11(8), 1972–1982. https://doi.org/10.1080/21645515.2015.1022008

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 21

66%

Researcher 11

34%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 19

50%

Agricultural and Biological Sciences 11

29%

Engineering 4

11%

Medicine and Dentistry 4

11%

Article Metrics

Tooltip
Mentions
News Mentions: 2
Social Media
Shares, Likes & Comments: 66

Save time finding and organizing research with Mendeley

Sign up for free